ClinVar Miner

Submissions for variant NM_144573.4(NEXN):c.784C>T (p.Arg262Ter)

dbSNP: rs1002648603
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000620205 SCV000737153 uncertain significance Cardiovascular phenotype 2016-09-01 criteria provided, single submitter clinical testing The p.R262* variant (also known as c.784C>T), located in coding exon 7 of the NEXN gene, results from a C to T substitution at nucleotide position 784. This changes the amino acid from an arginine to a stop codon within coding exon 7. This variant was not reported in population-based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), Exome Aggregataion Consortium (ExAC), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 5942 samples (11884 alleles) with coverage at this position. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. However, loss of function of NEXN has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Labcorp Genetics (formerly Invitae), Labcorp RCV001223312 SCV001395454 pathogenic Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 2022-10-03 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 519122). This variant has not been reported in the literature in individuals affected with NEXN-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg262*) in the NEXN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEXN are known to be pathogenic (PMID: 32058062, 32814711, 32870709, 33949776).
Fulgent Genetics, Fulgent Genetics RCV001223312 SCV002776484 uncertain significance Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 2021-11-18 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.